Annual Current Liabilities
$30.85 M
+$20.17 M+188.90%
31 December 2023
Summary:
BioLineRx annual total current liabilities is currently $30.85 million, with the most recent change of +$20.17 million (+188.90%) on 31 December 2023. During the last 3 years, it has risen by +$20.21 million (+189.94%). BLRX annual current liabilities is now at all-time high.BLRX Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$24.96 M
-$5.55 M-18.20%
30 September 2024
Summary:
BioLineRx quarterly total current liabilities is currently $24.96 million, with the most recent change of -$5.55 million (-18.20%) on 30 September 2024. Over the past year, it has increased by +$10.24 million (+69.52%). BLRX quarterly current liabilities is now -20.43% below its all-time high of $31.37 million, reached on 31 March 2024.BLRX Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BLRX Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +188.9% | +69.5% |
| 3 y3 years | +189.9% | +142.0% |
| 5 y5 years | +357.0% | +147.4% |
BLRX Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +217.4% | -20.4% | +206.9% |
| 5 y | 5 years | at high | +357.0% | -20.4% | +206.9% |
| alltime | all time | at high | +961.7% | -20.4% | +875.5% |
BioLineRx Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $24.96 M(-18.2%) |
| June 2024 | - | $30.52 M(-2.7%) |
| Mar 2024 | - | $31.37 M(+1.7%) |
| Dec 2023 | $30.85 M(+188.9%) | $30.85 M(+109.5%) |
| Sept 2023 | - | $14.72 M(+18.3%) |
| June 2023 | - | $12.45 M(+3.4%) |
| Mar 2023 | - | $12.04 M(+12.8%) |
| Dec 2022 | $10.68 M(+9.9%) | $10.68 M(+31.3%) |
| Sept 2022 | - | $8.13 M(-15.6%) |
| June 2022 | - | $9.63 M(+5.9%) |
| Mar 2022 | - | $9.10 M(-6.4%) |
| Dec 2021 | $9.72 M(-8.7%) | $9.72 M(-5.8%) |
| Sept 2021 | - | $10.31 M(+4.0%) |
| June 2021 | - | $9.92 M(-2.9%) |
| Mar 2021 | - | $10.22 M(-4.0%) |
| Dec 2020 | $10.64 M(-11.1%) | $10.64 M(+1.6%) |
| Sept 2020 | - | $10.48 M(-10.6%) |
| June 2020 | - | $11.72 M(-0.4%) |
| Mar 2020 | - | $11.77 M(-1.7%) |
| Dec 2019 | $11.97 M(+77.3%) | $11.97 M(+18.6%) |
| Sept 2019 | - | $10.09 M(+17.9%) |
| June 2019 | - | $8.56 M(+5.2%) |
| Mar 2019 | - | $8.13 M(+20.5%) |
| Dec 2018 | $6.75 M(+0.4%) | $6.75 M(+37.1%) |
| Sept 2018 | - | $4.92 M(-7.7%) |
| June 2018 | - | $5.34 M(-13.6%) |
| Mar 2018 | - | $6.18 M(-8.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2017 | $6.72 M(+83.6%) | $6.72 M(+21.6%) |
| Sept 2017 | - | $5.53 M(+2.1%) |
| June 2017 | - | $5.41 M(+4.6%) |
| Mar 2017 | - | $5.17 M(+41.3%) |
| Dec 2016 | $3.66 M(+16.6%) | $3.66 M(+8.7%) |
| Sept 2016 | - | $3.37 M(+20.0%) |
| June 2016 | - | $2.81 M(+9.6%) |
| Mar 2016 | - | $2.56 M(-18.5%) |
| Dec 2015 | $3.14 M(+8.1%) | $3.14 M(-12.5%) |
| Sept 2015 | - | $3.59 M(-13.5%) |
| June 2015 | - | $4.15 M(+0.2%) |
| Mar 2015 | - | $4.14 M(+42.6%) |
| Dec 2014 | $2.91 M(-4.8%) | $2.91 M(+11.1%) |
| Sept 2014 | - | $2.62 M(-5.0%) |
| June 2014 | - | $2.75 M(-13.7%) |
| Mar 2014 | - | $3.19 M(+4.5%) |
| Dec 2013 | $3.05 M(-52.5%) | $3.05 M(-29.5%) |
| Sept 2013 | - | $4.33 M(-16.6%) |
| June 2013 | - | $5.20 M(-30.3%) |
| Mar 2013 | - | $7.45 M(+15.9%) |
| Dec 2012 | $6.43 M(-4.9%) | $6.43 M(-4.3%) |
| Sept 2012 | - | $6.72 M(+3.8%) |
| June 2012 | - | $6.47 M(-12.6%) |
| Mar 2012 | - | $7.40 M(+9.6%) |
| Dec 2011 | $6.75 M | $6.75 M(+2.0%) |
| Sept 2011 | - | $6.62 M(-3.4%) |
| June 2011 | - | $6.85 M(+7.5%) |
| Mar 2011 | - | $6.38 M |
FAQ
- What is BioLineRx annual total current liabilities?
- What is the all time high annual current liabilities for BioLineRx?
- What is BioLineRx annual current liabilities year-on-year change?
- What is BioLineRx quarterly total current liabilities?
- What is the all time high quarterly current liabilities for BioLineRx?
- What is BioLineRx quarterly current liabilities year-on-year change?
What is BioLineRx annual total current liabilities?
The current annual current liabilities of BLRX is $30.85 M
What is the all time high annual current liabilities for BioLineRx?
BioLineRx all-time high annual total current liabilities is $30.85 M
What is BioLineRx annual current liabilities year-on-year change?
Over the past year, BLRX annual total current liabilities has changed by +$20.17 M (+188.90%)
What is BioLineRx quarterly total current liabilities?
The current quarterly current liabilities of BLRX is $24.96 M
What is the all time high quarterly current liabilities for BioLineRx?
BioLineRx all-time high quarterly total current liabilities is $31.37 M
What is BioLineRx quarterly current liabilities year-on-year change?
Over the past year, BLRX quarterly total current liabilities has changed by +$10.24 M (+69.52%)